Ethical and Genetic Aspects regarding Presymptomatic Testing for Neurodegenerative Diseases.

@article{Cozaru2016EthicalAG,
  title={Ethical and Genetic Aspects regarding Presymptomatic Testing for Neurodegenerative Diseases.},
  author={Georgeta Camelial Cozaru and Mariana Aşchie and Anca Florentina Mitroi and I Poinăreanu and E V Gorduza},
  journal={Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi},
  year={2016},
  volume={120 1},
  pages={15-22}
}
Neurodegenerative diseases, such as Alzheimer's dementia, Huntington's chorea, Parkinson's disease or spinocerebellar ataxia, manifests into adulthood with an insidious onset, slowly of progressive symptoms. All of these diseases are characterized by presimptomatic stages that preceded with many years of clinical debut. In Parkinson's disease, more than half of the dopaminergic neurons of the black substance are lost before the advent of motor characteristic manifestations. In Huntington's… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 40 references

Genetics of Alzheimer's disease

European Neuropsychopharmacology • 1990
View 6 Excerpts
Highly Influenced

Movement sequencing in Huntington disease.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry • 2014
View 2 Excerpts

A brief history of triplet repeat diseases.

Methods in molecular biology • 2013
View 1 Excerpt

Ethical issues and Huntington's disease.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…